Item 1.01 Entry into a Material Definitive Agreement
On
Pursuant to the Purchase Agreement, the Company agreed to acquire all of the
issued and outstanding equity securities of Cleared (the "Acquisition") in
exchange for (i) a payment equal to
Cleared is a privately held, telehealth company that provides personalized
treatments for allergy, asthma, and immunology to patients across
The Purchase Agreement contains customary representations, warranties and covenants by each of the parties, and contains indemnification provisions under which the parties have agreed, subject to certain limitations, to indemnify each other against certain liabilities. On the closing date of the Acquisition, the Company will deposit a portion of the Acquisition Consideration with an escrow agent to be held in escrow. The escrow amount may be used to account for indemnification claims and any post-closing adjustment of the Acquisition Consideration.
The closing of the Acquisition is subject to customary conditions, including, among others, (i) the absence of any governmental order that restrains, prevents or materially alters the transactions contemplated by the Purchase Agreement, (ii) the accuracy of the parties' representations and warranties contained in the Purchase Agreement (subject to certain qualifications), (iii) the parties' material compliance with the covenants and agreements in the Purchase Agreement, and (iv) the absence of a material adverse effect on the Company or Cleared. The Company expects the Acquisition to close in the first quarter of 2022.
The Purchase Agreement also contains customary pre-closing covenants, including the obligation of Cleared to conduct its business in all material respects in the ordinary course and to refrain from taking certain specified actions without the consent of the Company.
The Purchase Agreement is terminable at any time prior to closing by mutual
consent of the parties and in the following limited circumstances: (i) by the
Company if there is an uncured (within 10 days of written notice) breach by
Sellers that would result in the failure of a closing condition; (ii) by Sellers
if there is an uncured (within 10 days of written notice) material breach by the
Company that would result in the failure of a closing condition; (iii) by the
Company, if the Sellers or Cleared have not satisfied their respective closing
conditions as of
The foregoing description of the Purchase Agreement and the transactions contemplated therein does not purport to be complete and is qualified in its entirety by reference to the complete text of the Purchase Agreement, which is filed as Exhibit 2.1 to this Current Report on Form 8-K and incorporated herein by reference.
Item 3.02 Unregistered Sales of
The information provided in response to Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02.
The Company may issue shares of its common stock in lieu of cash as the Acquisition Consideration and Earn Out Consideration, if applicable, to persons who are "accredited investors" as defined in Rule 501 of Regulation D promulgated under the Securities Act of 1933, as amended (the "Securities Act"). The issuance of shares of common stock in lieu of cash as the Acquisition Consideration and Earn Out Consideration in the Acquisition will be made in reliance on the exemption from registration afforded under Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation D under the Securities Act.
Item 7.01 Regulation FD Disclosure.
On
The Company does not intend for this Item 7.01, Exhibit 99.1 to be treated as "filed" for purposes of the Securities Exchange Act of 1934, as amended, or incorporated by reference into its filings under the Securities Act of 1933, as amended.
Cautionary Statements Regarding Forward-Looking Information
Certain statements contained in this report that are not statements of
historical fact constitute forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Such statements include, but
are not limited to, certain plans, expectations, goals, projections and benefits
relating to the Acquisition, which are subject to numerous assumptions, risks
and uncertainties. Words such as ''believes,'' ''anticipates,'' "likely,"
"expected," "estimated," ''intends'' and other similar expressions are intended
to identify forward-looking statements but are not the exclusive means of
identifying such statements. Please refer to the Company's Report on Form 10-K
for the year ended
Forward-looking statements are not historical facts but instead express only
management's beliefs regarding future results or events, many of which, by their
nature, are inherently uncertain and outside of the management's control. It is
possible that actual results and outcomes will differ, possibly materially, from
the anticipated results or outcomes indicated in these forward-looking
statements. In addition to factors previously disclosed in reports filed by the
Company with the
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 2.1* Stock Purchase Agreement, dated as ofJanuary 11, 2022 99.1 Press Release, datedJanuary 12, 2022 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
*Schedules and exhibits to the Stock Purchase Agreement have been omitted. A
copy of any omitted schedule or exhibit will be furnished supplementally to the
© Edgar Online, source